Synergy between TGF-beta and anti-IgM in growth inhibition of CD5+ B-cell lymphomas.
Warner
G L
GL
Immunology and Immunotherapy Division, University of Rochester Cancer Center, New York 14642.
Nelson
D O
DO
Scott
D W
DW
D000818:Animals; D000906:Antibodies; D015703:Antigens, CD / Q000276:immunology / Q000502:physiology*; D018956:CD5 Antigens; D002455:Cell Division / Q000187:drug effects; D007075:Immunoglobulin M / Q000276:immunology*; D007700:Kinetics; D016393:Lymphoma, B-Cell / Q000276:immunology*; D051379:Mice; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000906:Antibodies; D015703:Antigens, CD; D018956:CD5 Antigens; D007075:Immunoglobulin M; D016212:Transforming Growth Factor beta